FII, DII data: FPIs bought shares worth Rs 331 cr, DIIs added shares worth Rs 703 cr on August 10, Thursday Foreign institutional investors (FII) bought shares worth net Rs 331.22 crore, while domestic institutional investors (DII) added shares worth net Rs 703.72 crore on August 10, 2023, according to the provisional data available on the NSE. For the month till August 10, 2023, FIIs sold shares worth net Rs 4,473.25 crore while DIIs bought shares worth net Rs 4,853.21 crore. In the month of July, FIIs bought shares worth net Rs 13,922.01 crore while DIIs sold equities worth net Rs 1,184.33 crore. “Volume profile indicates Index has a strong support around 19,300 – 19,400 zone. Coming to the OI Data, on the call side, the highest OI was observed at 19,600 followed by 19,700 strike prices while on the put side, the highest OI is at 19,500 strike price. On the other hand, Bank nifty has support at 44,200 – 44,300 while resistance is placed at 44,900 – 45,000 levels,” Deven Mehata added. On Thursday, domestic indices ended in the red after RBI MPC kept the key repo rates unchanged and raised the inflation forecast. The NSE Nifty 50 tanked 89.45 points or 0.46% to 19,543.10 and BSE Sensex sank 307.63 points or 0.47% to 65,688.18. In sectoral indices, Bank Nifty plunged 338.90 points or 0.76% to 44,541.80, Nifty FMCG tumbled 0.91%, Nifty Pharma fell 0.74, Nifty PSU Bank plunged 0.81% while Nifty Media jumped 6.63%. The top gainers on Nifty 50 were Adani Enterprises, Adani Ports, IndusInd Bank, Titan and ONGC while the losers were Asian Paints, Kotak Bank, Britannia, ITC and Nestle India. Foreign institutional investors (FII) or Foreign portfolio investors (FPI) are those who invest in the financial assets of a country while not being part of it. On the other hand, domestic institutional investors (DII), as the name suggests, invest in the country they’re living in. Political and economic trends impact the investment decisions of both FIIs and DIIs. Additionally, both types of investors – foreign institutional investors (FIIs) and domestic institutional investors (DIIs) – can impact the economy’s net investment flows.
2. Warren Buffett talked about his business partner Charlie Munger in his letter. He said they both think alike but what it takes Warren Buffett a page to explain, Charlie Munger sums up in a sentence. Charlie Munger’s version, moreover, is always more clearly reasoned.
The lesson for investors: “I will add to Charlie’s list a rule of my own: Find a very smart high-grade partner – preferably slightly older than you – and then listen very carefully to what he says,” Warren Buffett said.
3. Warren Buffett emphasised that his long-time business partner Charlie Munger and he are business pickers, not stock pickers. He further said that efficient markets exist only in textbooks.
“We own publicly-traded stocks based on our expectations about their long-term business performance, not because we view them as vehicles for adroit purchases and sales. That point is crucial: Charlie and I are not stock-pickers; we are business pickers,” Warren Buffett said.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.